A breast cancer vaccine for people with an inherited BRCA1, BRCA2 or PALB2 mutation

Questions To Ask Your Health Care Provider

For people who are diagnosed with TNBC or have residual disease after chemotherapy and are taking Keytruda:

• Are any clinical trials of vaccines to treat breast cancer right for me?
• Am I considered at high risk for a recurrence of my cancer?

For people who have never been diagnosed with breast cancer who have a BRCA1, BRCA2 or PALB2 mutation:

• Are any clinical trials of vaccines to prevent cancer right for me?
• Are there any other medications I can take to lower my risk for breast cancer?

Open Clinical Trials

The following are breast cancer screening or prevention studies enrolling people at high risk for breast cancer.   

• NCT04067726: Denosumab and Mammographic Density in Premenopausal Women With Dense Breasts (TRIDENT). This study is looking at the drug denosumab to learn if it can reduce breast density in high-risk premenopausal women who have dense breasts. 
• The Risk Factor Analysis of Hereditary Breast and Ovarian Cancer In Women  with BRCA1, BRCA2 or PALB2 Mutations. This study seeks to improve researchers’ understanding of how hormonal, reproductive and lifestyle factors may be associated with cancer in high-risk people.
• NCT02620852: Women Informed to Screen Depending on Measures of Risk (WISDOM) study. The goal of this study is to determine if breast cancer screening can be improved by personalizing each woman’s mammogram schedule, compared to the current one-size-fits-all annual approach.

• NCT04674306: Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer. This study is testing a new vaccine to lower the risk of breast cancer in high-risk women with an inherited mutation in BRCA1, BRCA2 or PALB2. 

Additional risk-management clinical trials for people at high risk for breast cancer may be found here.